Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

Who holds ELVNENLIVEN THERAPEUTICS

17 funds on our shelf carry ENLIVEN THERAPEUTICS — heaviest hand: CANC at 2.76% of its book.

FundWeightFund assetsShares held
CANCTema Oncology ETF2.76%—119,584
XPHState Street SPDR S&P Pharmaceuticals ETFINDEX1.66%$487M183,446
BBCVirtus Biotech Clinical Trials ETF0.81%—5,425
MEDIHarbor Health Care ETFACTIVE0.78%$17M6,976
IHEiShares U.S. Pharmaceuticals ETFINDEX0.63%$1.6B225,141
DWASInvesco Dorsey Wright SmallCap Momentum ETFINDEX0.41%$411M33,246
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.23%$112M6,154
IBBiShares Biotechnology ETFINDEX0.20%$10.6B462,892
FFSMFidelity Fundamental Small-Mid Cap ETFINDEX0.20%$86M58,033
IWOiShares Russell 2000 Growth ETFINDEX0.19%$14B548,991
VTWGVanguard Russell 2000 Growth ETFINDEX0.17%$1B63,610
AVSCAvantis U.S Small Cap Equity ETFACTIVE0.16%$1.4B106,711
BIBProShares Ultra Nasdaq BiotechnologyINDEX0.15%$92M3,076
NUSCNuveen ESG Small-Cap ETF0.13%$1.2B33,400
FBCGFidelity Blue Chip Growth ETFACTIVE0.04%$2B61,528
FHLCFidelity MSCI Health Care Index ETFINDEX0.03%$3.2B25,413
VHTVanguard Health Care Index FundINDEX0.03%$19B147,874

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.